2026-01-15 - Analysis Report
**Company Overview:** Albemarle Corp is a leading global specialty chemicals company.

**Simple Analysis:**

**Return Rate Comparison:**
- Cumulative return of review stock: 58.37%
- Cumulative return of comparison stock (S&P 500, VOO): 92.89%
- Degree of divergence (simply the difference in cumulative return on the last day of the data): -34.52 (not provided so I used 92.89 - 58.37 instead for a better idea)
- Divergence (current): -50.10
- Relative divergence: 23.50%

- Note: The stock's return rate is lower compared to the S&P 500.

**Alpha, Beta Analysis:**
- Year | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | -10.0% | 35.3% | -13.0% | 1.2 | 9.1B |
| 2017-2019 | -37.0% | 35.3% | -54.0% | 1.2 | 8.6B |
| 2018-2020 | 50.0% | 29.5% | 29.0% | 1.2 | 17.4B |
| 2019-2021 | 140.0% | 29.5% | 96.0% | 1.3 | 27.5B |
| 2020-2022 | 134.0% | 28.5% | 136.0% | 1.3 | 25.5B |
| 2021-2023 | -26.0% | 53.3% | -27.0% | 1.5 | 17.0B |
| 2022-2024 | -139.0% | 68.7% | -158.0% | 1.5 | 10.1B |
| 2023-2025 | -165.0% | 74.5% | -227.0% | 1.8 | 16.6B |

**Recent Stock Price Fluctuations:**
- Close: $177.51
- Last-market: {'price': 177.55, 'previousClose': 176.88, 'change': 0.38}
- 5-day SMA: $168.66
- 20-day SMA: $151.19
- 60-day SMA: $125.30
- **Note:** The stock price has slightly increased over the last market day.

**RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence:**
- Market Risk Indicator: 0.70 (Medium Investment Recommended, as the value is between 0.7 and 0.9)
- RSI: 78.28 (Overbought territory, between 70 and 80)
- PPO: 1.18 (Positive, above 1)
- Expected Return: 7.60% (compared to S&P 500)
- Recent relative divergence change: 4.40 (+: improving)

**Recent News & Significant Events:**
- Multiple news articles indicate recent surge in the stock price due to increased lithium demand and analyst ratings update.

**Analyst Opinions:**
- Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 2.35 (~Buy)
  - Opinions: 23
  - Target Price (avg/high/low): 142.79 / 210.00 / 80.00

**Recent Earnings Analysis:**
| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-11-05 | -1.72 | 1.31 B$ |
| 2025-08-04 | -0.16 | 1.33 B$ |
| 2025-04-30 | 0 | 1.08 B$ |
| 2024-11-06 | -9.45 | 1.35 B$ |
| 2025-11-05 | -9.45 | 1.35 B$ |

- **Note:** The company's recent earnings per share are lower than the year prior, while revenue is similar.

**Financial Information (Revenue and Profitability):**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.31B | 8.99% |
| 2025-06-30 | $1.33B | 14.80% |
| 2025-03-31 | $1.08B | 14.51% |
| 2024-12-31 | $1.23B | 11.22% |
| 2024-09-30 | $1.35B | -7.68% |

- **Note:** The company's profit margins have varied across quarters, but overall are increasing.

**Financial Information (Capital and Profitability):**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $10.00B | -1.61% |
| 2025-06-30 | $10.24B | 0.22% |
| 2025-03-31 | $10.03B | 0.41% |
| 2024-12-31 | $9.96B | 0.76% |
| 2024-09-30 | $10.24B | -10.44% |

- **Note:** The company's returns on equity have fluctuated across quarters.

**Comprehensive Analysis:**
- The stock is slightly lower compared to S&P 500 (58.37% vs 92.89%), with recent divergence of -50.10 and relative divergence of 23.50%.
- The company's earnings have experienced a decline in some quarters, while revenue remains relatively similar.
- Analysts predict a buy, with a target price of $142.79.
- The recent surge in lithium demand may be causing stock price fluctuations.
- The company has experienced varying profit margins and returns on equity across quarters.
- Investors may want to keep monitoring these factors before making an investment decision.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.